13 C] glucose and L-[indole-2- 13 C] tryptophan into indocarbazostatin B (2) was observed in a biosynthetic study using a mutant strain, Streptomyces sp. MUV-7-8. The original strain, Streptomyces sp. TA-0403 produced a small amount of indocarbazostatin (1) and indocarbazostatin B (2), which displayed potent biological activities. To facilitate biosynthetic studies, we selected high indocarbazostatin producing mutant strains. The first mutants, Streptomyces sp. MUV-6-83 and MUV-6-17, produced indocarbazostatins C (3) and D (4) as well as 1 and 2. When the production medium was supplemented with D-tryptophan, the MUV-6-17 mutant produced K252c (5), whereas when L-tryptophan was added, it produced K252d (6). On further UV treatment of the mutant strain MUV-6-83, we finally obtained a new mutant producer, Streptomyces sp. MUV-7-8, that produced 2 as a major metabolite with higher productivity. This mutant producer enabled us to do a feeding experiment of the envisioned precursors, glucose and tryptophan.
Introduction
We were able to discover indocarbazostatin (1) and indocarbazostatin B (2) as novel inhibitors of NGF-induced neuronal differentiation in PC12 cells [1ϳ3] . The productivities of 1 and 2 were 1.2 mg and 0.9 mg, respectively, from 35 liters of a culture broth of the original producer, Streptomyces sp. TA-0403. The biological activity of 1 was more potent than that of a known inhibitor, K252a [4] . There was some difference between indocarbazostatins and other known indolocarbazole antibiotics in their molecular shape, because of the opposite absolute configurations at C-3Ј of all of the indocarbazostatins and the atropisomeric chirality in the 7bϳ7c axes of 2 and 4 [3, 5] . To approach the biosynthetic study of these unique compounds, we decided to treat the original producer by repeated UV irradiation. After irradiation with UV six times, we obtained Streptomyces sp. MUV-6-83 and MUV-6-17 that produced new analogs, indocarbazostatins C (3) and D (4) together with 1 and 2 [5] . Since instability was observed in the productivity of the mutant, the incorporation experiment of a labeled precursor failed. The improved mutant producer, Streptomyces sp. M-UV-7-8, was obtained by another UV treatment of Streptomyces sp. MUV-6-83. The new mutant showed high specificity in the productivity of 2 as a major metabolite that is easy to separate. In this paper, we report the precise selection procedure of the producer of indocarbazostatins, identification of K-252c (5) and K-252d (6) [6] in a broth of a mutant producer, control of metabolite production by adding tryptophan, incorporation of putative precursors, D-[U- 13 C 6 ] glucose and L-[indole-2-13 C] tryptophan into 2 using a new mutant strain, Streptomyces sp. MUV-7-8 ( Fig. 1 ). A slant culture of the mutant, Streptomyces sp. MUV-6-17, was inoculated into twenty 500 ml K-1 flasks each containing 50 ml of the culture medium consisting of glucose 0.5%, soluble starch 2%, NZ Case (Humko Sheffield Chemical Co.) 0.3%, yeast extract 0.3%, fish meal 0.5%, CaCO 3 0.2% (pH 6.5 before sterilization). The flasks were incubated at 30°C for 2 days on a rotary shaker (200 rpm). The seed culture (2 ml) was transferred into a hundred 500 ml K-1 flasks each containing 50 ml of the production medium consisting of glucose 0.43%, soluble starch 2.17%, soybean meal 0.59%, corn steep liquor 0.59%, Pharmamedia 1.18%, yeast extract (Difco Laboratories) 0.2%, NaCl 0.3%, MgSO 4 · 7H 2 O 0.05%, CaCO 3 0.3%, and Diaion HP-20 (Mitsubishi Chemical Co.) 1%, L-tryptophan 0.1% (pH 7.0). Another seed culture (2 ml) was transferred into a hundred 500 ml K-1 flasks each containing 50 ml of the production medium consisting of the above components except for addition of Dtryptophan instead of L-tryptophan. Both fermentations were carried out at 30°C for 4 days on a rotary shaker. The combined culture was centrifuged into mycelium and supernatant, and the mycelium was extracted with 10 liters of acetone. The acetone extract was partitioned into CHCl 3 and H 2 O. The CHCl 3 layer was evaporated in vacuo, and the residue was subjected to silica gel column chromatography (8 cm i.d.ϫ20 cm, silica gel 40 m m, CHCl 3 : CH 3 OHϭ20 : 1) followed by reversed-phase column chromatography (3 cm i.d.ϫ20 cm, Cosmosil 40 C 18 -PREP, The seed culture (2 ml) was transferred into twenty 500 ml K-1 flasks each containing 100 ml of the production medium consisting of glucose 0.43%, soluble starch 2.17%, soybean meal 0.59%, corn steep liquor 0.59%, Pharmamedia 1.18%, yeast extract (Difco Laboratories) 0.2%, NaCl 0.3%, 0.05%, CaCO 3 0.3%, and Diaion HP-20 (pH 7.0). One day after fermentation, 1% of D-[U- 13 C 6 ] glucose was added to each flask. The culture was continued for another 4 days. The culture broth was centrifuged into mycelium and supernatant, the mycelium was extracted with acetone to give 5 g of extract. The acetone extract was partitioned between CHCl 3 and H 2 O. The CHCl 3 layer was evaporated in vacuo to give 1.2 g of a syrup, the residue was subjected to silica gel column chromatography (5 cm i.d.ϫ10 cm, Silica Gel 60N, hexane : acetoneϭ3 : 2) to afford 41.3 mg of crude indocarbazostatins. The crude sample was separated on a HPLC column (2 cm i.d.ϫ25 cm, Mightysil RP-18) eluting with 75% CH 3 OH to yield 5.4 mg of Mars yellow syrup. The crude material was crystallized from acetone to give 3.8 mg of purified 13 Clabeled indocarbazostatin B (8) . The NMR measurements of 8 were carried out in DMSO-d 6 using a 2.5 mm NMR micro tube (WILMAD, 520-1A for Bruker microprobe).
Material and Methods

Chemicals
Isolation of 13 C-Labeled Indocarbazostatin B (9) from a Culture Broth of Streptomyces sp. MUV-7-8 Fermented in the Presence of L-[indole-2-
C] Tryptophan
The seed culture (2 ml) as noted above was transferred into twenty 500 ml K-1 flasks each containing 100 ml of the production medium consisting of glucose 0.43%, soluble starch 2.17%, soybean meal 0.59%, corn steep liquor 0.59%, Pharmamedia 1.18%, yeast extract (Difco Laboratories) 0.2%, NaCl 0.3%, CaCO 3 0.3%, and Diaion HP-20 (pH 7.0). One day after fermentation, 0.05% of L-[indole-2- 13 C] tryptophan was added to each flask. The culture was continued for another 4 days. The culture broth was centrifuged into mycelium and supernatant, and the mycelium was extracted with acetone to give 6 g of extract. The acetone extract was partitioned between CHCl 3 and H 2 O. The CHCl 3 layer was evaporated in vacuo to give 1.1 g of a syrup, which was subjected to silica gel column chromatography (5 cm i.d.ϫ10 cm, Silica Gel 60N, hexane : acetoneϭ3 : 2) to afford 29.0 mg of crude materials. The crude sample was purified on a HPLC column (2 cm i.d.ϫ25 cm, Mightysil RP-18) eluting with 75% CH 3 OH to yield 5 mg of Mars yellow syrup. The syrup was crystallized from benzene to give 1.7 mg of purified 13 Clabeled indocarbazostatin B (9) and 2.2 mg of a residue from the mother liquor. NMR measurements of 9 were done in DMSO-d 6 using a 2.5 mm symmetrical micro tube (SHIGEMI, DMS-0025).
Instruments for Structural Determination
Optical rotation was measured with a Horiba SEPA-300 spectrometer. UV spectra were recorded on a BECKMAN DU-600 spectrophotometer, 1 H NMR spectra were measured on a JEOL JNMEX-270, a JNM-La400, a Bruker AMX-500 spectrometers, and MS spectra were recorded on a JEOL JMS-AX500 instrument. Assignment of 3 spore/ml) were irradiated with UV light (253.7 nm) for 0, 15, 30, 45, 60, 75 and 90 seconds at the distance of 25 cm under the UV lamp. Single spore isolation was performed using the plates that showed lethal rates of which were around 99.91ϳ99.95%. Two hundred single colonies were picked after three days incubation on SK#2 agar plate (soluble starch 2%, glucose 0.5%, yeast extract 0.5%, bactopeptone 0.5%, meat extract 0.3%, KH 2 PO 4 0.02%, MgSO 4 · 7H 2 O 0.06%, agar 2%, pH 7.6). A high-producing mutant was selected and mutated again using the same method. After 6 times repeated mutation of each isolated mutant, we obtained a highproducing mutant, Streptomyces sp. MUV-6-17, that produced other indocarbazole antibiotics, as well as a highproducing mutant MUV-6-83 that showed slightly different HPLC profile. In the case of the mutant MUV-6-17, addition of 0.1% D-tryptophan in the production medium remarkably enhanced the productivities of 1, 3 and peaks at 21 minutes on the HPLC (Mightysil RP-18, 4.6 mm i.d.ϫ250 mm, 0.6 ml/minute, solvent A: CH 3 CN 30ϳ70%; B: 0.1% CH 3 COOH; linear gradient: 0ϳ40 minutes; 40°C), and slightly enhanced those of 4 and a peak at 19 minutes but not 2, whereas L-tryptophan dominantly enhanced the productivities of 1 and a peak at 19 minutes on the HPLC, enhancements of 2, 3 and 4 were weak in this case. The two peaks at 19 minutes and 21 minutes showed characteristic UV absorption patterns of an indolo[2,3-a]pyrrolo[3,4-c]carbazole-5(6H)-one system. We therefore decided to isolate these compounds and identified the peaks at 21 minutes and 19 minutes to be K252c (5) and K252d (6), respectively (Table 1) . Time course of the productivities of these compounds showed that 5 and 6 did not shift to 1ϳ4 and did not disappear in even 9 days' cultivation (data not shown). These data suggested that 5 and 6 may be shunt products but not direct precursors of indocarbazostatins.
Results and Discussion
Mutation of
Incorporation of D-[U-
C 6 ] Glucose into Indocarbazostatin B (2)
To approach a biosynthetic study of indocarbazostatins, we carried out further mutation of Streptomyces sp. MUV-6-83 by UV irradiation. A new mutant producer, Streptomyces sp. MUV-7-8 which dominantly produced indocarbazostatin B (2), was inoculated into 500-ml K-1 flasks each containing 70 ml of the seed medium. After 2 days' culture, the seed culture (2 ml) was transferred into twenty 500 ml K-1 flasks each containing 100 ml of the production medium without tryptophan and MgSO 4 · 7H 2 O, because the productivity of 2 redoubled without the Mg ion and was not affected by addition of L, D or D,L-tryptophan. One day after fermentation, 1% of D-[U- 13 C 6 ] glucose was added to each flask. The culture was continued for another 4 days. The culture broth was centrifuged into mycelium and supernatant, the mycelium was extracted with acetone. The acetone extract was partitioned between CHCl 3 and H 2 O.
The CHCl 3 layer was evaporated in vacuo to give a syrup, which was subjected to silica gel column chromatography (hexane : acetoneϭ3 : 2) to afford 41.3 mg of crude materials. The crude sample was separated on a HPLC column (Mightysil RP-18) eluting with 75% CH 3 OH to yield 5.4 mg of Mars yellow syrup. The syrup was crystallized from acetone to give purified 13 
C-labeled indocarbazostatin B (8). Incorporation of D-[U-
13 C 6 ] glucose into the sugar moiety of 8 was determined by 1D-INADEQUATE experiment, which revealed the direct incorporation of D-[U- 13 C 6 ] glucose. In the same experiment, incorporation of D-[U- 13 C 6 ] glucose into the aglycon moiety was also observed. L-Tryptophan would be derived from glucose through the shikimic acid pathway. To avoid such randomization of labeled glucose as in the case of biosynthetic studies of staurosporine [7] , the precursor was added to the culture one day after inoculation that starts the accumulation of 2. The result afforded characteristic 13 C-13 C couplings at C-7b-C-12a, and C-4b-C-12b but not at C-7-C-7a, C-7c-C-11a, C-8-C-9-C-10-C-11, C-4c-C-5, C-4a-C-13a, C-1-C-2-C-3-C-4 in 8 ( Table 2, Fig. 2 ). The labeled three-carbon unit, C-3-C-4-C-5 of the ribosyl moiety would be lost as glyceraldehyde-3-phosphate in the tryptophan biosynthesis [8] as shown in Fig. 2 . Thus glucose is precursor of the sugar moiety of indocarbazostatins and L-tryptophan is that of aglycon of 2 as in the case of staurosporine. The relative productivity was calculated from the area ratio of each peak to the peak area of incocarbazostatin (1) into twenty 500 ml K-1 flasks each containing 100 ml of the production medium modified to be free of tryptophan and MgSO 4 . One day after fermentation, 0.05% of L-[indole-2-13 C] tryptophan was added to each flask. The culture was continued for another 4 days. The culture broth was centrifuged into mycelium and supernatant, the mycelium was extracted with acetone to give a crude extract, which was partitioned between CHCl 3 and H 2 O. The CHCl 3 layer was evaporated in vacuo to give a residue, which was subjected to silica gel column chromatography (hexane : acetoneϭ3 : 2) to afford crude materials. Purification of the crude materials was carried out on a HPLC column (Mightysil RP-18) eluting with 75% CH 3 OH to yield 5 mg of a Mars yellow syrup. The syrup was crystallized from benzene to afford 1.7 mg of purified 13 C-labeled indocarbazostatin B (9). The 13 C NMR of 9 showed the distinctly enriched signals at C-12a (relative intensity 17.7) and C-12b (relative intensity 11.5) with a couple of strong doublet signals (J 12a,12b ϭ76.5 Hz) as shown in Table 2 and Fig. 3 , thereby establishing that 9 was produced from two intact tryptophan units as in the case of staurosporine biosynthesis [9] (Fig. 4) .
Incorporation of L-[indole-2-
The Proposal Biosynthetic Pathway of Indocarbazostatins in Streptomyces sp. MUV-7-8
The structure units, a pyranose derived from glucose and aglycon derived from two tryptophan units, would be connected between the N-13 position and the anomeric position at C-5Ј by N-glycosyltransferase. Another C-N bond formation might be catalyzed by an oxidase such as P450 homolog as in the case of staurosporine biosynthesis [10ϳ12]. The putative 1,2-diketone (A) would rearrange to furanose-type structure (B) by stereoselective benzil-benzilic acid rearrangement. This type of benzilbenzilic acid rearrangement would thermodynamically afford K-252a type compound but not C-3Ј-epi compounds such as indocarbazostatins 1ϳ4 as shown in the synthetic study of K-252a [13] . Thus critical oxidation reaction would occur to give 1,2-diketone which leads to stereoselective ring contraction in the same active site of the oxidase, and this unique oxidase would have a 3-dimensional structure in the active site that makes it possible to construct the thermodynamically unfavorable structure to give hindered indocarbazostatins (Fig. 4) . Recently, increasing amount of information has become available on the molecular genetics of indolocarbazole biosynthesis [14ϳ17]. Cloning of a biosynthetic gene cluster of indocarbazostatins in Streptomyces sp. MUV-7-8 might clarify this unique oxidase homolog as well as the monoamineoxygenase homolog that constructs the atropisomeric chirality in the 7b~7c axis of indocarbazostatin B (2).
In conclusion, attempts to enhance productivity of indocarbazostatins by mutating the original producer, Streptomyces sp. TA-0403, with UV irradiation, led to acquirement of a high-producing mutant, Streptomyces sp. MUV-6-83 and MUV-6-17. Streptomyces sp. MUV-6-17 produced K-252c (5) in the presence of D-tryptophan, whereas K-252d (6) was produced in the presence of L-tryptophan in the production medium. Although Ltryptophan improved the productivity of indocarbazostatin 764 (1) and 6, and D-tryptophan enhanced the productivities of 1, 3 and 5, additive effects of L-or D-tryptophan in the productivities of 2 and 4 were much less than those of the other metabolites. The addition of Diaion HP-20 was effective for the production of indocarbazostatins and its related compounds. We next focused our attention on a biosynthetic study of indocarbazostatins, and obtained a suitable mutant, Streptomyces sp. MUV-7-8, for this purpose. Streptomyces sp. MUV-7-8 mainly produced 2, which was hardly affected by tryptophan addition. D-[U- 13 C] Glucose was directly incorporated into the sugar moiety and indirectly incorporated in aglycon of 2, whereas L-[indole-2- 13 C] tryptophan was directly incorporated in aglycon of 2 to give 13 C labeled indocarbazostatin B, 8 and 9, respectively in these feeding experiments using this mutant. The final assignment of 13 C NMR of indocarbazostatin B in DMSO-d 6 shown in Table 2 
